The room was likely beige. The chairs, standard issue for diplomatic conferences. The air carried the faint scent of paper and coffee. On January 12, 1998, representatives from nineteen European nations laid their pens down on a document that addressed a creature which did not exist: a cloned human.
The event generated no dramatic headlines. It was not a response to an achievement, but a preemptive strike against a possibility. Dolly the sheep had been cloned two years prior. The genie, as commentators liked to say, was out of the bottle. The international community, particularly in Europe, felt a collective shudder at the logical, and perhaps inevitable, next step. The Council of Europe’s Additional Protocol to the Convention on Human Rights and Biomedicine was an attempt to bottle the genie back up, at least within their borders.
The language was unambiguous: “Any intervention seeking to create a human being genetically identical to another human being, whether living or dead, is prohibited.” The signatories included France, Germany, Italy, Spain. Notably, the United Kingdom did not sign, opting for its own, more flexible regulatory approach. The act was a remarkable moment of consensus on a frontier science. It was not a ban on cloning techniques—which held promise for medicine—but a specific, ethical fence built around the concept of a human copy. They drew a line not in sand, but in international law, declaring that some doors, once seen, should be locked before anyone even reaches for the handle. It was governance trying to outpace science, an attempt to define the limits of humanity before technology could blur them.